0 Items
Select Page

Rotavirus

Rotavirus is a contagious virus that can cause gastroenteritis. Symptoms include severe, watery diarrhoea, vomiting, fever and abdominal pain. Infants and young children are most likely to contract rotavirus disease. Patients can become severely dehydrated, require hospitalisation and can even die.

The Native Antigen Company has developed a highly specific monoclonal antibody for research into Rotavirus infection.

Rotavirus Background

The genus rotavirus belongs to the Reoviridae family of viruses. Rotaviruses are non-enveloped, double-stranded RNA (dsRNA) viruses, capable of infecting animals, birds and humans. In the mature virion, a complex triple-layered viral capsid surrounds a genome, composed of eleven segments of dsRNA. These RNA segments code for 6 structural and 6 non-structural proteins (CDC). Rotavirus are classified according to the serological reactivity and genetic variability of the structural VP6 protein. Currently, eight species of rotavirus are recognised and are referred to as groups A-H. Group A rotaviruses are the most common cause of human disease, but group B and C rotaviruses have also been found to infect humans.

Rotavirus is transmitted from person-to-person by the faecal-oral route, via contact with faeces contaminated clothing, surfaces and infected individuals. Occasionally, the virus can be transmitted via respiratory droplets produced by coughing or sneezing. Rotavirus infection is the most common cause of severe diarrhoea in infants and young children worldwide. Symptoms of rotavirus infection include lethargy, fever, vomiting, abdominal pain, severe watery diarrhoea and dehydration. Severe dehydration can often lead to hospitalisation and in some cases death. Rotavirus infection in older children and adults may be mild or even asymptomatic.

Effective vaccines are available which have helped to reduce severe diarrhoea and childhood mortality caused by rotavirus infection. However, rotavirus continues to have a major global impact on childhood morbidity and mortality, particularly in developing countries (WHO).

References

  1. Centers for Disease Control and Prevention: Rotavirus
  2. World health organization: Rotavirus

Rotavirus Antibodies

Our monoclonal rotavirus antibody, clone R15, is specific to the VP6 structural protein of rotavirus. R15 does not cross-react with other organisms causing gastrointestinal infection, including Campylobacter spp., Clostridium difficile, Escherichia coli, Listeria monocytogenes, Salmonella spp., Shigella spp., Yersinia enterocolitica, Enterovirus, Norovirus, Astrovirus, Adenovirus, Cryptosporidium parvum, Giardia lamblia, Helicobacter pylori, Entamoeba histolytica, Staphylococcus aureus.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Using Adenoviruses to Fight Cancer

In the second of a 2-part series, we discuss how adenoviruses are being developed to treat cancer and some of the hurdles these platforms face from our own immune systems. Curing cancer is one of the biggest challenges of the 21st century. Our knowledge of cancer’s...

New Immunofluorescence Data for our CMV, Yellow Fever and Ebola Antibodies

In September 2018 The Native Antigen Company and Virology Research Services (VRS) were awarded the Medical Research Council (Proximity to Discovery Award for Knowledge Exchange) to test a large panel of our viral antibodies in immunofluorescence applications. This...

Why are ticks such good vectors of pathogens?

In this blog, Professor Patricia Nuttall discusses what makes ticks such effective vectors of pathogens and how we might prevent the spread of tick-borne diseases. About Patrica Nuttall Pat Nuttall is Emeritus Professor of Arbovirology in the Department of Zoology,...

Dengue in 2019

What's going on with dengue? Dengue virus (DENV) has been in the news a lot recently. The number of reported cases continues to climb year-on-year and 2019 has been especially bad. Rio de Janeiro has seen a 45% increase in dengue cases in the first two months of 2019...

Zika Prevalence in Suriname – an insight into assay cross-reactivity

A recent study published by Langerak et al tested for the seroprevalence of Zika virus in Suriname populations and evaluated the comparative effectiveness of using a commercial ELISA and a standard Virus Neutralisation Assay. Here we discuss the study, its results,...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

3 + 12 =

Live Customer Feedback